Feedback
Make this your Home
News Markets Mutual Funds IPO Commodities Wealth Portfolio Messages Videos Mail CNBC-TV18
CNBC-TV18 Matrix SENSEX 17198.95 67.87 NIFTY 5108.15 17.60
 

Piramal Life Sciences Cash Flow, Piramal Life Sciences Financial Statement & Accounts

Piramal Life Sciences

BSE: 532979  |  NSE: PIRLIFE  |  ISIN: INE122J01015  |  Pharmaceuticals

Print/Copy to Excel :
« Previous Years  

Cash Flow of Piramal Life Sciences

------------------- in Rs. Cr. -------------------
Mar '08 Mar '09
12 mths 12 mths
Net Profit Before Tax -91.47 -110.04
Net Cash From Operating Activities 19.26 -69.12
Net Cash (used in)/from
Investing Activities
-19.63 -54.27
Net Cash (used in)/from Financing Activities 0.53 125.44
Net (decrease)/increase In Cash and Cash Equivalents 0.16 2.05
Opening Cash & Cash Equivalents 0.00 0.16
Closing Cash & Cash Equivalents 0.16 2.21
Source : Religare Technova
Explore Piramal Life connections